Medical oncologist Andrew Seidman discussed Memorial Sloan Kettering’s collaboration with IBM Watson and the benefits it will bring to treating patients, and medical oncologist Victoria Blinder discussed psycho-social issues that can come into play when a person is going through cancer treatment.
Visible Ink Founder Judith Kelman was interviewed about the program that offers patients at Memorial Sloan Kettering the opportunity to work one-on-one with an experienced mentor on a writing project of their choice.
Memorial Sloan Kettering launched a transformative initiative to improve the quality of cancer care and the lives of cancer patients. Hartford HealthCare was selected as a pioneering member of the newly formed Memorial Sloan Kettering Cancer Alliance.
Memorial Sloan Kettering Physician-in-Chief José Baselga commented on the recommendation from a federal advisory panel to approve the first drug that would be used in early-stage breast cancer patients, prior to surgery.